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Abstract
Background: Testosterone (T) controls male Syrian hamster sexual behavior, however, neither of T’s primary metabolites,
dihydrotestosterone (DHT) and estradiol (E2), even in highly supraphysiological doses, fully restores sexual behavior in
castrated hamsters. DHT and T apparently interact with androgen receptors differentially to control male sexual behavior
(MSB), but whether these two hormones act synergistically or antagonistically to control MSB has received scant
experimental attention and is addressed in the present study.
Methodology/Principal Findings: Sexually experienced male Syrian hamsters were gonadectomized and monitored 5
weeks later to confirm elimination of the ejaculatory reflex (week 0), at which time they received subcutaneous DHT-filled or
empty capsules that remained in situ for the duration of the experiment. Daily injections of a physiological dose of 25 mgT
or vehicle commenced two weeks after capsule implantation. MSB was tested 2, 4 and 5 weeks after T treatment began.
DHT capsules were no more effective than control treatment for long-term restoration of ejaculation. Combined DHT + T
treatment, however, restored the ejaculatory reflex more effectively than T alone, as evidenced by more rapid recovery of
ejaculatory behavior, shorter ejaculation latencies, and a greater number of ejaculations in 30 minute tests.
Conclusions/Significance: DHT and T administered together restored sexual behavior to pre-castration levels more rapidly
than did T alone, whereas DHT and vehicle were largely ineffective. The additive actions of DHT and T on MSB are discussed
in relation to different effects of these androgens on androgen receptors in the male hamster brain mating circuit.
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Introduction
Testosterone (T) has long been implicated in the maintenance of
male sex behavior (MSB) [1–3]. In many mammals reduced
androgen availability is associated with marked reductions in
copulatory behavior. In some species androgens exert their effects
directly on androgen receptors (ARs); in others, conversion of T by
brain tissues may be an essential step [4]. The canonical view,
derived from studies of rats, emphasizes conversion of T to
estradiol (E2) by the enzyme aromatase as a key step in nervous
system maintenance of MSB. Treatment with 5a-dihydrotestos-
terone (DHT) or E2 alone is not sufficient to maintain ejaculation
in most castrated rats; combined treatment with both hormones
maintains full copulatory ability, although less effectively than T
treatment [5]. Physiologically relevant E2 plus DHT treatments
that elevate brain androgen and estrogen receptor levels to those
of castrated rats treated with T capsules that restore MSB, fail to
reinstate copulation [6]. Nevertheless, both androgenic and
estrogenic metabolites are thought to contribute to MSB in rats
[7–8].
Because DHT, a non-aromatizable steroid, effectively maintains
MSB in guinea pigs, rhesus monkeys, rabbits (reviewed in [9]), and
some mouse strains [10], the generality of the aromatization
hypothesis has been questioned. It remains unclear which of T’s
metabolites is critical for MSB in species other than rats [11].
In Syrian hamsters supraphysiological concentrations of E2 or
DHT fail to restore MSB [12–13]. In a typical study only a
cocktail of E2 and DHT that generates blood concentrations more
than two orders of magnitude greater than those in intact males
restores copulatory behavior, but even then not to the high levels
displayed by intact males [12–13]; the biological relevance of such
non-physiological treatments is questionable. Administration of
the aromatase inhibitor fadrozole does not compromise any
component of copulatory behavior in intact male Syrian hamsters,
despite inhibiting brain formation of E2 from T [14].
Nuclear binding of T to the AR in brain and peripheral tissues is
abolished when an excess of DHT is given simultaneously with T
[15] and pretreatment with DHT suppresses binding of T [16]. In
Syrian hamsters both DHT and T are ligands for ARs [17] and T
treatment concurrent with injection of labeled DHT completely
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whether separate ARs mediate effects of T and DHT [19–20],
several investigators have suggested that these two androgens
activate different target genes or that two kinds of androgen-
response elements mediate differential AR transactivation by T
and DHT [21–22]. In Syrian hamsters T and DHT differentially
affect harderian gland mRNA [23], suggesting that the two
hormones may activate different genes after binding to the AR.
Based on these considerations we reasoned that if DHT and T
occupy the same ARs, then treatment with a supraphysiological
dose of DHT (8 times the endogenous concentration), that by itself
does not support MSB, might inhibit the ability of otherwise
effective T treatment to restore MSB. This presupposes that the
DHT pretreatment saturates or substantially reduces the number
of ARs available to T. Alternatively, if T and DHT act at different
ARs, pretreatment with DHT may facilitate activation of MSB by
low physiological dose T replacement, possibly by increasing total




All animal procedures were approved by the Animal Care and
Use Committee at the University of California, Berkeley and were
conducted in compliance with the NIH guide for the care and use
of animals. Approval ID for this study is R084-0910C.
Animals
Syrian hamsters (Mesocricetus Auratus; HsdHan: Aura; 10 weeks
old) obtained from Harlan (Indianapolis, IN) were maintained on
a 14L:10D photoperiod (14 h light/day, lights off at 1800 h PST).
Tap water and Lab Diet Prolab 5P00 were continuously available.
Hamsters were singly housed at 2361uC in polypropylene cages
(48625621 cm) furnished with Tek-Fresh Lab Animal Bedding
(Harlan Teklab, Madison, WI).
Experimental Procedure
Screening for male sexual behavior. Adult male hamsters
were 12 weeks old at the time they were screened in real time for
MSB during the late portion of the light phase (,1400–1700 h)
with ovariectomized females rendered sexually receptive with
standard estradiol plus progesterone treatments [25]. A Silastic
capsule (Dow Corning, Midland, MI; 4 mm in length; ID
1.98 mm, OD 3.18 mm) filled with estradiol-17b (Sigma, St.
Louis, MO) and sealed with silicone adhesive, was implanted s.c.
on the day of ovariectomy; behavioral receptivity was induced by
injecting females s.c. with 350 mg progesterone (Sigma) dissolved
in peanut oil (2.5 mg/ml) 4 h prior to the sexual behavior testing
sessions. Females were not utilized more frequently than once
every four days.
The testing arena, kept in the room in which hamsters were
housed, consisted of a clear Plexiglass box (41621621 cm) set
above a slanted mirror to facilitate observation of intromissions
and ejaculations. After 10 min, during which the male was
acclimated to the apparatus, a sexually receptive female was
introduced and MSB recorded. Males that ejaculated on two
consecutive tests separated by at least a week were retained for the
experiment. During the first screening test observations were
limited to 15 min, which was adequate for each male to ejaculate
at least once. On the second screening test hamsters were observed
for 30 min, which permitted the emergence of the full suite of
behaviors and provided baseline data for comparison with
postoperative measures.
We recorded the number of mounts not accompanied by an
intromission that preceded ejaculation, the number of intromis-
sions that preceded ejaculation, latencies to the first mount, first
intromission, and first ejaculation. Males that failed to display any
of the behaviors during postoperative tests were assigned the
maximum latency of 30 min for each behavior. After the
preoperative tests, hamsters were assigned to groups that did not
differ with respect to any of the recorded behaviors.
Surgical procedures. Hamsters were anesthetized with
isoflurane vapors (Baxter Healthcare, Deerfield, IL) and castrated
through a midline incision in the abdominal cavity. Incisions were
closed with sterile sutures and wound clips (Mikron Auto Clip
9 mm, Becton Dickinson, Franklin Lakes, NJ). Hamsters were
injected s.c. with the analgesic 5% buprenorphine (0.1 ml/animal),
postoperatively (Hospira Inc., Lake Forest, IL).
Experimental Design. Sexually experienced males were re-
tested 5 weeks after castration (wk 0) to verify the loss of MSB,
characterized by absence of intromission and ejaculation behaviors.
The day after loss of MSB was verified, hamsters were treated s.c.
with three Silastic capsules (Dow Corning; 10 mm each in length;
ID 1.98 mm, OD 3.18 mm) that were either empty (blank) or
packed with powdered DHT. Capsule size was selected to generate
supraphysiological concentrations of DHT likely to compete
effectively with much lower doses of injected T, thereby providing
a test of the ability of DHT to influence restoration of MSB by T.
Beginning two weeks after capsule implantation, hamsters were
injected daily s.c. with 0.1 ml of a 50/50% ethanol-distilled water
solution that contained either 25 mg T or no hormone. This
concentration was selected based on a previous study that
established 15 mg T as a near threshold dose for restoration of
MSB in hamsters [26]. The four treatment groups, each containing
ten hamsters, received either Blank implants + Vehicle injections
(control), Blank implants + T injections (T), DHT implants +
Vehicle injections (DHT), or DHT implants + T injections (DHT +
T). Sexual behavior was tested in the same manner as in the final
pre-operative testing session, except tests were terminated if a
hamster failed to intromit after 10 min. Tests occurred 4, 6, and
7 wks after implantation of capsules, corresponding to 2, 4, and
5 wks after the start of daily injections. Behavior tests commenced
5–7 h after the most recent injection.
T was administered in an aqueous rather than oil vehicle,
because the former preparation is more effective for restoration of
hamster MSB [26]. 50 mg/day T in oil failed to restore MSB [12],
whereas 15 mg of aqueous T/day restored the ejaculatory reflex in
100% of castrated males [26]. The latter procedure was adopted
in the present study on the assumption that T treatments that
generate blood hormone concentrations orders of magnitude
greater than those present physiologically [12] reduce the
possibility of detecting interactions of T and DHT in the control
of MSB. The physiologically relevant T replacement regimen of
25 mg/day [26] elevates blood T concentrations for several hours
each day and more closely mimics the episodic secretion of T in
intact males [27] than hormone replacement via implanted
capsules or administration in oil vehicles (reviewed in [25–26]).
Blood and tissue analysis. All hamsters were bled one day
after the wk 5 behavior test, 2 h after injection of hormone or
vehicle. Blood was obtained from the retro-orbital sinus from
hamsters lightly anesthetized with isoflurane vapors. Samples were
centrifuged at 4uC for 20 min at 3000 rpm, and the serum
collected and frozen at 280uC until assayed for concentrations of
T, DHT and E2. Two subgroups were formed from the DHT
hamsters depending on whether the individual ejaculated after
replacement treatment (4 hamsters) or failed to ejaculate (6
hamsters generated 4 samples derived by pooling sera from 2 pairs
DHT and Sex Behavior
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T concentrations from unpooled samples were determined for 4
hamsters from the DHT + T group, 4 hamsters from the T group
and 5 hamsters from the control group. Unpooled samples from 6
hamsters from the DHT + T group, 6 from the T group, and 5
from control group were assayed for E2. The new groups created
for blood hormone determinations did not differ with respect to
sexual behavior within groups; i.e., T-injected hamsters assayed
for T did not differ from T-injected hamsters assayed for E2.
Approximately 48 h after the final behavior test hamsters were
euthanized by placement in a carbon dioxide-filled chamber; the
seminal vesicles, ventral prostate, and penis were removed, and
dry weights recorded (60.01 mg).
Hormone radioimmunoassay. Hormone concentrations
were measured with commercially available radioimmunoassay
kits (Diagnostic Systems Laboratory, Inc, Webster, TX) previously
validated for use with non-extracted Syrian hamster serum, which
included a description of parallelism upon serial dilution, and a
recovery of 94% [28]. The T and DHT assays (DSL 4000 and
9600, respectively), were validated for Syrian hamster serum by
Faruzzi et al. [29].
Samples for T were assayed in duplicate (DSL-4000), whereas
samples for E2 were determined in singleton (DS-43100), owing to
the larger sample volume requirement of that assay. Serum
samples underwent an oxidation/extraction procedure prior to the
DHT assay (DSL-9600). The intra-assay correlations of variation
for T, E2, and DHT were 8.9, 2.0, and 3.1%, respectively, and the
minimum detection limits were 0.08 ng for T, 0.01 ng for E2, and
0.004 ng/ml for DHT, respectively. Samples were run in a single
assay for each hormone. Cross-reactivity with T was 0.02% in the
DHT assay after extraction; in the T assay cross-reactivity with
DHT was 5.8%, as reported by the manufacturer.
Statistical analyses. Differences between pre- and
postoperative sex behaviors were assessed with paired t-tests. Mixed
ANOVAs compared postoperative, hormone-treated groups across
time. Differences between groups at specific time points or for post-
mortem tissue weight analyses were assessed with single factor
ANOVA followed by pairwise comparisons using Tukey’s HSD test.
If an omnibus ANOVA could not be carried out due to too few data
points in some groups, those groups were excluded from analyses;
e.g., at wk 5 no hamsters from the vehicle group and only one from
the DHT group ejaculated, which does not allow for statistical
comparison; thus, these groups were eliminated from the analysis.
Comparisons of proportions of hamsters in each group displaying a
behavior were calculated with the Fisher-Freeman-Halton Exact
Test. The Statview program (Statview 5; SAS Institute, Cary, NC)
Figure 1. DHT and T synergize to accelerate restoration of ejaculatory behavior. Percent of males displaying the ejaculatory reflex (A),
number of ejaculations per 30 min test (B) and ejaculation latencies on the first ejaculatory series (C), during post-castration tests 2–5 wks after the
onset of hormone or vehicle injections. * Significantly different from all other groups. ‘‘a’’ significantly different from the control group (p,0.05).
doi:10.1371/journal.pone.0012749.g001
DHT and Sex Behavior
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Exact test was computed with the Statsdirect program (Statsdirect
2.7.7; Altrincham, UK). Observed differences were considered
significant if p,0.05 and are reported as such.
Results
There were no differences between groups in the numbers of
hamsters displaying mounts, intromissions, or ejaculations during
pre-operative testing. All hamsters failed to intromit or ejaculate 5
weeks after castration (wk 0 test).
Restoration of male sexual behavior after hormone
treatments
Ejaculatory Behavior. All hamsters were treated with DHT
or empty capsules beginning 2 wks prior to the start of the
injection regimen; capsules remained in situ for the duration of the
experiment. None of the control males treated with blank capsules
and subsequently injected with vehicle displayed the ejaculatory
reflex during any of the post-operative tests. After 2 wks of
hormone injection, however, ejaculatory behavior was displayed
by 90% of the DHT + T group, compared to 30% of the T group
(p,0.05) and 20% of the DHT males (Fig. 1A, wk 2, p,0.05).
Combined treatment with both hormones substantially accelerated
reinstatement of ejaculatory behavior. After 5 wks of treatment
(wk 5, Fig. 1A), 90% of males in both the DHT + T and T groups
ejaculated, compared to 10% of the DHT males (p,0.05). With
continued treatment T was as effective as DHT + T in restoring
the ejaculatory reflex in 90% of males. DHT and control males did
not differ significantly at any time point.
The number of ejaculations per test differed significantly across
time (F3,35=61.1, p,0.05) and a significant group 6 time
Figure 2. DHT + T treatment reduces the number of intromissions preceding ejaculation. Number of intromissions (A) and intromission
latencies (B), preceding the first ejaculation. * Significantly different from all other groups ‘‘a’’ significantly different from control group). ‘‘b’’
significantly different from DHT + T group.
doi:10.1371/journal.pone.0012749.g002
Figure 3. T and DHT + T treatments do not affect number of mounts but reduce mount latencies. Number of mounts (A) and mount
latencies (B) preceding the first ejaculation. ‘‘a’’ significantly different from control group ‘‘b’’ significantly different from DHT + T group. Mount
numbers did not differ significantly between groups over time.
doi:10.1371/journal.pone.0012749.g003
DHT and Sex Behavior
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ejaculated significantly more often than each of the other 3 groups
(Fig. 1B). The time between wks 2 and 4 accounted for this
interaction (p,0.05). By wks 4 and 5, all groups differed
significantly from each other except for the DHT and control
hamster comparison (Fig. 1B). The number of ejaculations by
males treated with both hormones did not differ from preoperative
values, indicative of full restoration of MSB, whereas males treated
with just T ejaculated significantly less often than during
preoperative testing.
Hormone treatment significantly affected ejaculation latencies
(ELs) across groups (F3,36=51.5, p,0.05); ELs were significantly
shorter for DHT + T hamsters than for all other groups at wks 2
and 4 (Fig. 1C); by wk 5, ELs were equal in the DHT + T and T
groups. Only treatment with DHT + T restored ELs to
preoperative values. At wks 4 and 5, ELs of the T group were
significantly shorter than those of the control and DHT hamsters.
Again, there was a significant interaction between the groups and
time (p,0.05), with the changes between wks 2 and 4 accounting
for this effect (p,0.05).
Intromission Behavior. DHT + T hamsters displayed
significantly fewer intromissions prior to ejaculation than T
hamsters at wks 2, 4 and 5 (Fig. 2A). Values for DHT + T
hamsters at wk 5 did not differ significantly from preoperative
values; T hamsters, incontrast,had substantially more intromissions
prior to ejaculation at wk 5 than preoperatively (p,0.05).
Hormone treatment significantly altered intromission latencies
(ILs) across time (F3,35=40.2, p,0.05); hamsters that failed to
intromit during all postoperative behavior tests were assigned the
30 min default value. There was no interaction between group
and time (p.0.05). DHT + T and T males maintained
preoperative-like ILs at wks 2, 4, and 5, that were significantly
shorter than those of the control and DHT groups. By wk 5, DHT
was no more effective than vehicle at reducing ILs.
Mounting Behavior. After non-ejaculators were excluded
from the data analysis, the number of mounts that preceded the
first ejaculation did not differ among groups (F2,11=1.1, p.0.05;
Fig. 3A). In addition, there was no significant interaction between
the time and group factors (p.0.05). Mount latencies (MLs)
differed significantly as a function of hormone treatment
(F3,35=33.2, p,0.05). T and DHT + T groups had significantly
shorter MLs than did the control and DHT groups at wks 2, 4 and
5; DHT and control groups did not differ significantly (p.0.05).
The T and DHT + T groups maintained MLs during all
postoperative tests that did not differ significantly from
preoperative values.
Ventral Prostate, Seminal Vesicle and Penis Weights.
Differential hormone treatment resulted in significantly different
ventral prostate and seminal vesicle weights (F3,35=24.0,
F3,35=97.9, respectively, p,0.05). Administration of DHT,
either alone or in combination with T, resulted in significantly
increased ventral prostate and seminal vesicle weights compared
to those of other groups (Fig. 4A, 4B; respectively) but the DHT
+ T and DHT groups did not differ. T administration alone did
not increase ventral prostate weight, but did significantly
increase seminal vesicle weight, compared to values of vehicle-
treated controls. Penile weights did not differ significantly based
on a single factor ANOVA analysis (F3,35=2.4, p=0.11;
Fig. 4C).
Blood hormone concentrations. T and DHT + T
injections each significantly elevated T concentrations compared
to the vehicle-injected control group; the T and DHT + T groups
did not differ from each other (Fig. 5A).
Both T and control groups, had significantly lower E2
concentrations than the DHT + T group. DHT males that had
ejaculated on one or more of the tests (n=4) had significantly
higher DHT concentrations than those that did not ejaculate
(p,0.05; Fig. 5C).
Figure 4. DHT alone or in combination with T increases
prostate and seminal vesicle but not penis weights. Ventral
prostate (A) seminal vesicle (B) and penis weights (C) (mg). Bars
designated with different letters differ significantly from one another
DHT increased prostate and seminal vesicle weights.
doi:10.1371/journal.pone.0012749.g004
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Pretreatment with DHT, although itself ineffective for restoring
MSB, combined with T to restore copulatory behavior to values
generated by intact males. Any competition of these steroids for
available ARs did not negatively affect the display of MSB. On the
contrary, after two weeks, the combined treatment was far more
effective than T alone in restoring MSB. This is the first such
demonstration in any mammal, except for an unpublished study
by Arteaga-Silva et al. ([13] p. 419), who noted that ‘‘…simulta-
neous treatment with T and DHT is more effective than T alone
to restore MSB in castrated hamsters’’. The more rapid restoration
of MSB by DHT + T treatment may involve metabolism of DHT
to 3b–diol, a hormone effective in restoring MSB in rats via
actions on ER-b [30]. This metabolite restored sexual behavior in
,half of the rats tested by Morali et al. [31], but was only fully
effective when co-administered with DHT. Our observation that
E2 concentrations were twice as high in the DHT + T than in T-
treated or control hamsters does not preclude the involvement of
estrogens in activation of MSB. Both DHT and its metabolite, 3b-
diol, can upregulate aromatase activity, which may account for
these differences [32]; there is, however, little definitive evidence
for the regulation of the ejaculatory reflex by E2 in Syrian
hamsters. Nor is it known whether or not brain ER-b activation
affects MSB in Syrian hamsters. Circulating E2 concentrations in
the present study were much lower than those necessary to
synergize with DHT to partially restore MSB [12].
The more rapid restoration of MSB by DHT + T treatment
suggests an additive effect of T and DHT on the hamster brain
mating circuit [33] or more effective restoration of penile spines by
DHT than T [13], but behavioral potency of steroids did not
correlate with stimulation of penile growth [13].
The long-term maintenance of localized nuclear ARs by DHT
pretreatment also may contribute to decreased latencies for
restoration of MSB by T in castrated males. Two months after
castration, steady-state brain AR mRNA is decreased; adminis-
tration of DHT restores values in the bed nucleus of the stria
terminalis and medial preoptic area of rats to within the intact
range [34–35]. DHT may accelerate resumption of MSB in
response to T treatment through rapid reinstatement of AR
mRNA, or by inducing higher levels of AR protein [30], thereby
yielding more binding sites for the T ligand. Blood DHT
concentrations generated by the implants were an order of
magnitude higher than those reported for intact hamsters [12] and
well above concentrations generated by 5 mm implants that
‘‘maintain androgen receptor immunoreactivity exclusively within
the neuronal cell nucleus’’ [36], which suggests that our dose of
DHT was sufficient. AR occupancy may be necessary but is not a
sufficient condition for activation of MSB in Syrian hamsters [37].
The complete pattern of MSB was restored in 90% of hamsters
by daily injection of a physiological dose of 25 mg T, but the
number of ejaculations was reduced well below preoperative
values and the number of intromissions preceding ejaculation
increased substantially, suggesting that this was a suboptimal
replacement regimen. The T dose employed in the present study
was much lower than those typically administered in replacement
protocols (500–1000 mg); it generated blood T concentrations
twice the normal physiological value of 2 ng/ml for a short time,
with decreases to below 0.9 ng/ml no later than 7 h after injection
[26]. The amount of T present for most of the interval between
injections is unlikely to compete effectively with DHT for ARs,
given chronic DHT concentrations of ,1.3 to 2.0 ng/ml
produced by the Silastic capsule implants. Approximately 10
times higher concentrations of T are required to produce the AR
transcription effects of DHT [38].
DHT restored MSB in a small number of hamsters, but less
robustly than in hamsters treated with T or DHT + T, as
evidenced by increased latencies to intromit and ejaculate; longer
ejaculation latencies in DHT than T-treated males were previously
reported [39]. When analyses were restricted to hamsters that
ejaculated, latencies were similar in DHT and T-treated hamsters.
This effect was transient, however, as only one of the DHT
hamsters that ejaculated at wk 4 also ejaculated at wk 5. It is
unknown why DHT is much less effective than T for restoring
MSB in Syrian hamsters or whether 5-a reduction of T to DHT is
implicated in the control of MSB in intact males.
T treatment increased seminal vesicle but not ventral prostate
weights. Higher doses of T restore both tissues to preoperative
values [40]. In the presence of the low dose of T administered in the
present study sensitivity of the seminal vesicles to T is greater than
that of the ventral prostate. DHT was effective at increasing both
seminal vesicle and ventral prostate weights to the same extent, with
or without T supplementation, which confirms many earlier studies
that DHT is more potent than T in maintaining peripheral
androgen-responsive tissues. The seminal vesicle and prostate
weights, were, however, lower than those of intact males in a
previous study from our laboratory [25], suggesting that treatment
duration or steroid doses were suboptimal for these tissues.
To the extent that DHT competes with T for AR binding sites,
it does not interfere with sex behavior-promoting actions of T.
Rather, MSB is facilitated by co-administration of the two
hormones, which may attest to their differing interactions with
the AR, to unexplored effects of DHT metabolites, or to the
greater duration or amount of androgen exposure in hamsters
treated with both hormones.
Acknowledgments
We are grateful to Daniel Yu and Tiffany Seto for data collection, and
Chris Tuthill, Kim Pelz, Valerie Salerno, and the UC Berkeley Office of
Laboratory Care for technical assistance.
Author Contributions
Conceived and designed the experiments: DJP IZ. Performed the
experiments: DJP. Analyzed the data: DJP NJP IZ. Contributed
reagents/materials/analysis tools: NJP IZ. Wrote the paper: DJP NJP IZ.
References
1. Young WC (1961) The hormones and mating behavior. In: Young WC, ed. Sex
and Internal Secretions. Baltimore: Williams & Wilkins. pp 1173–1239;
vol. 2.
2. Larsson K (1979) Features of the neuroendocrine regulation of masculine sexual
behavior. In: Beyer C, ed. Endocrine Control of Sexual Behavior. New York:
Raven Press. pp 77–163.
Figure 5. T and DHT + T elevate blood T concentrations; DHT + T increases E2 concentrations. Higher DHT concentrations are associated
with increased ejaculatory behavior. (A) Testosterone, (B) estradiol, and (C) dihydrotestosterone concentrations. Bars designated with different letters
differ significantly from one another N=4–5 for each of the groups in panel A and 5–6 in panel B. C. N=4 and 6 for hamsters that ejaculated or were
non-ejaculators, respectively.
doi:10.1371/journal.pone.0012749.g005
DHT and Sex Behavior
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e127493. Hull EM, Meisel R, Sachs BD (2002) Male sexual behavior. In: Pfaff DW,
Arnold AP, Etgen AM, Fahrbach SE, Rubin RT, eds. Hormones, Brain, and
Behavior. New York: Academic Press. pp 1–137; vol. 1.
4. Ball GF, Balthazart J (2009) Androgen metabolism and the activation of male
sexual behavior: it’s more complicated than you think! Horm Behav 49: 1–3.
5. Putnam SK, Sato S, Riolo JV, Hull EM (2005) Effects of testosterone
metabolites on copulation, medial preoptic dopamine, and NOS-immunoreac-
tivity in castrated male rats. Horm Behav 45: 513–522.
6. McGinnis MY, Dreifuss RM (1989) Evidence for a role of testosterone-androgen
receptor interactions in mediating masculine sexual behavior in male rats.
Endocrinology 124: 618–626.
7. Putnam SK, Sato S, Hull EM (2003) Effects of testosterone metabolites on
copulation and medial preoptic dopamine release in castrated male rats. Horm
Behav 44: 419–426.
8. Baum MJ (2003) Activational and organizational effects of estradiol on male
behavioral neuroendocrine function. Scand J Psychol 44: 213–220.
9. Sachs BD, Meisel RL (1988) The physiology of male sexual behavior. In:
Knobil E, Neill JD, eds. The Physiology of Reproduction. New York: Raven
Press. pp 1393–1485.
10. Luttge WG, Hall NR (1973) Differential effectiveness of testosterone and its
metabolites in the induction of male sexual behavior in two strains of albino
mice. Horm Behav 4: 31–43.
11. Whalen RE, Yahr P, Luttge WG (1985) The role of metabolism in hormonal
control of sexual behavior. In Adler NT, Pfaff D, Goy RW, eds. Handbook of
Behavioral Neurobiology: Reproduction. New York: Plenum Press. pp 609–663,
vol. 7.
12. Arteaga-Silva M, Ma ´rquez-Villanueva Y, Martı ´nez-Garcı ´a R, Herna ´ndez-
Gonza ´lez M, Bonilla-Jaime H, et al. (2005) Effects of hormonal replacement
with androgens and estrogens on male sexual behavior and plasma levels of these
steroids in gonadectomized golden hamsters (Mesocricetus auratus). Physiol Behav
85: 571–580.
13. Arteaga-Silva M, Vigueras-Villasen ˜or RM, Retana-Ma ´rquez S, Herna ´ndez-
Gonza ´lez M, Chihuahua-Serrano C, et al. (2008) Testosterone, androstenedi-
one, and 5a-dihydrotestosterone on male sexual behavior and penile spines in
the hamster. Physiol Behav 94: 412–421.
14. Cooper TT, Clancy AN, Karom M, Moore TO, Albers HE (2000) Conversion
of testosterone to estradiol may not be necessary for the expression of mating
behavior in male Syrian hamsters (Mesocricetus auratus). Horm Behav 37:
237–245.
15. Schleicher G, Stumpf WE, Gurley JM, Drews U (1989) Differential nuclear
binding of [
3H]testosterone and its metabolites to androgen and estrogen
receptors in brain, pituitary, heart, kidney and accessory sex glands of the mouse:
an autoradiographic study. J Steroid Biochem 33: 581–587.
16. Zaka ´r T, To ´th M (1980) Studies on the androgen receptor of the rat seminal
vesicle: comparison of the binding characteristics of dihydrotestosterone and
testosterone. J Steroid Biochem 13: 743–750.
17. Wood RI, Brabec RK, Swann JM, Newman SW (1992) Androgen and estrogen
concentrating neurons in chemosensory pathways of the male Syrian hamster
brain. Brain Res 596: 89–98.
18. Doherty PC, Sheridan PJ (1981) Uptake and retention of androgen in neurons of
the brain of the golden hamster. Brain Res 219: 327–334.
19. Sholl SA, Goy RW (1981) Dynamics of testosterone, dihydrotestosterone and
estradiol-17 beta uptake and metabolism in the brain of the male guinea pig.
Psychoneuroendocrinology 6: 105–111.
20. Sheridan PJ (1991) Can a single androgen receptor fill the bill? Mol Cell
Endocrinol 76: C39–C45.
21. Lu S, Simon NG, Wang Y, Hu S (1999) Neural androgen receptor regulation:
effects of androgen and antiandrogen. J Neurobiol 41: 505–512.
22. Hsiao PW, Thin TH, Lin DL, Chang C (2000) Differential regulation of
testosterone vs. 5alpha-dihydrotestosterone by selective androgen response
elements. Mol Cell Biochem 206: 169–175.
23. Domı ´nguez P, Antolı ´n I, Boga JA, Urı ´a H, Mene ´ndez-Pela ´ez A (1994) Androgen
regulation of gene expression in the Syrian hamster Harderian gland. Mol Cell
Endocrinol 106: 81–89.
24. Lynch CS, Story AJ (2000) Dihydrotestosterone and estrogen regulation of rat
brain androgen-receptor immunoreactivity. Physiol Behav 69: 445–453.
25. Park JH, Paul MJ, Butler MP, Villa P, Burke M, et al. (2007) Short duration
testosterone infusions maintain male sex behavior in Syrian hamsters. Horm
Behav 52: 169–176.
26. Piekarski DJ, Routman DM, Schoomer EE, Driscoll JR, Park JH, et al. (2009)
Infrequent low dose testosterone treatment maintains male sexual behavior in
Syrian hamsters. Horm Behav 55: 182–189.
27. Pieper DR, Lobocki CA (2000) Characterization of serum dehydroepiandros-
terone secretion in golden hamsters. Proc Soc Exp Biol Med 224: 278–284.
28. Gutzler SJ, Karom M, Erwin WD, Albers HE (2009) Photoperiodic regulation of
adrenal hormone secretion and aggression in female Syrian hamsters. Horm
Behav 56: 481–489.
29. Faruzzi AN, Solomon MB, Demas GE, Huhman KL (2005) Gonadal hormones
modulate the display of submissive behavior in socially defeated female Syrian
hamsters. Horm Behav 47: 569–575.
30. Oliveira AG, Coelho PH, Guedes FD, Mahecha GA, Hess RA, et al. (2007)
5alpha-Androstane-3beta, 17beta-diol (3beta-diol), an estrogenic metabolite of
5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta
expression in the ventral prostrate of adult rats. Steroids 72: 914–922.
31. Morali G, Oropeza MV, Lemus AE, Perez-Palacios G (1994) Mechanisms
regulating male sexual behavior in the rat: role of 3 alpha- and 3 beta-
androstanediols. Biol Reprod 51: 562–571.
32. Roselli CE, Horton LE, Resko JA (1987) Time-course and steroid specificity of
aromatase induction in rat hypothalamus-preoptic area. Biol Reprod 37:
628–633.
33. Wood RI (1997) Thinking about networks in the control of male hamster sexual
behavior. Horm Behav. 1997 32: 40–45.
34. Handa RJ, Kerr JE, DonCarlos LL, McGivern RF, Hejna G (1996) Hormonal
regulation of androgen receptor messenger RNA in the medial preoptic area of
the male rat. Mol Brain Res 39: 57–67.
35. Burgess LH, Handa RJ (1993) Hormonal regulation of androgen receptor
mRNA in the brain and anterior pituitary gland of the male rat. Mol Brain Res
19: 31–38.
36. Wood RI, Newman SW (1999) Androgen receptor immunoreactivity in the male
and female Syrian hamster brain. J Neurobiol 39: 359–370.
37. Meek LR, Romeo RD, Novak CM, Sisk CL (1997) Actions of testosterone in
prepubertal and postpubertal male hamsters: dissociation of effects on
reproductive behavior and brain androgen receptor immunoreactivity. Horm
Behav 31: 75–88.
38. Askew EB, Gampe RT, Jr., Stanley TB, Faggart JL, Wilson EM (2007)
Modulation of androgen receptor activation function 2 by testosterone and
dihydrotestosterone. J Biol Chem. 282: 25801–25816.
39. Powers JB, Bergondy ML, Matochik JA (1985) Male hamster sociosexual
behaviors: effects of testosterone and its metabolites. Physiol Behav 35: 607–616.
40. Crescioli C, Ferruzzi P, Caporali A, Scaltriti M, Bettuzzi S, et al. (2004)
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for
a phase II clinical trial in patients with benign prostate hyperplasia.
Eur J Endocrinol 150: 591–603.
DHT and Sex Behavior
PLoS ONE | www.plosone.org 8 September 2010 | Volume 5 | Issue 9 | e12749